EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Outcomes of Lung Transplantation From Asphyxiation Donors: Reassessing Hypoxic Injury and Implications for Donation After Circulatory Death

Ye In Christopher Kwon iD, Matthew Ambrosio, Michael Keller, Chadi A Hage, Gary Schwartz, Suresh Keshavamurthy, Vipul Patel, Rachit D Shah, Vigneshwar Kasirajan, Zubair A Hashmi

Interdisciplinary CardioVascular and Thoracic Surgery · 05.05.2026 · 41 (5)

DOI: 10.1093/icvts/ivag108 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Interdisciplinary CardioVascular and Thoracic Surgery, online erschienen am 09.04.2026. Verfasst von Ye In Christopher Kwon und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiothoracic Surgery, Department of Surgery, Pauley Heart Center, Virginia Commonwealth University School of Medicine, Richmond, VA, 23…. Hauptthemen laut MEDLINE: Lung Transplantation, Tissue Donors, Asphyxia, Donor Selection. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

With persistent donor shortages limiting lung transplantation (LT), optimizing the use of extended-criteria donors is essential. Asphyxiation (AXP) and donation after circulatory death (DCD) donors both experience hypoxic–ischaemic injury, raising concern for graft performance. We evaluated the long-term outcomes of AXP donor LT and the effect of ex vivo lung perfusion (EVLP) on survival.

Methods

Adult recipients (≥18 years) of primary LT (2014-2024) in the United Network for Organ Sharing registry were stratified by donor cause of death: AXP vs non-AXP. Survival was estimated by Kaplan–Meier analysis, and multivariable Cox regression identified factors associated with mortality. Subgroup analyses examined EVLP and DCD vs donation after brain death (DBD) cohorts.

Results

Among 26 334 LT recipients, 1406 (5.3%) received AXP donor lungs. Asphyxiation donors were more frequently DCD (9.5% vs 6%, P < .001). Ten-year recipient (25.2% vs 27.4%; P = .67) and graft (24.1% vs 26.8%; P = .72) survival were comparable, and AXP status was not independently associated with mortality after adjusting for allocation era (HR 1.01, 95% CI, 0.91-1.11, P = .908). However, EVLP use in AXP lungs correlated with decreased 3-year survival (55.3% vs 74.1%; P = .035). Sensitivity analyses demonstrated significant differences among the 4 donor subgroups (DCD-AXP, DCD non-AXP, DBD-AXP, and DBD non-AXP) on overall comparison (P = .008), with DCD-AXP recipients exhibiting numerically the highest 5-year survival rates.

Conclusions

AXP donor lungs provide comparable long-term outcomes, and DCD-AXP grafts do not appear to confer inferior survival. The interaction between AXP and EVLP use warrants further study to refine donor reconditioning strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung TransplantationTissue DonorsAsphyxiaDonor SelectionHypoxiaTissue and Organ ProcurementHumansFemaleMaleMiddle AgedAdultGraft SurvivalRegistriesRisk FactorsRetrospective StudiesTreatment OutcomeBrain Death

Stichwörter der Autor:innen

asphyxiation donorsdonation after circulatory deathex vivo lung perfusiongraft survivallung transplantation

Autor:innen und Institutionen

  • Division of Cardiothoracic Surgery, Department of Surgery, Pauley Heart Center, Virginia Commonwealth University School of Medicine, Richmond, VA, 23298, United States.
  • Department of Biostatistics, Virginia Commonwealth University School of Population Health, Richmond, VA, 23298, United States.
  • Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine, Department of Internal Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, 15213, United States.
  • Department of Thoracic Surgery, Baylor University Medical Center, Dallas, TX, 75246, United States.
  • Department of Cardiovascular and Thoracic Surgery, University of Texas Southwestern Medical Center, Dallas, TX, 75390, United States.
  • Division of Pulmonary Disease and Critical Care Medicine, Department of Internal Medicine, Hume-Lee Transplant Center, Virginia Commonwealth University School of Medicine, Richmond, VA, 23298, United States.

ORCID-Profile: Ye In Christopher Kwon

Zitieren

APA

Kwon, Y. I. C., Ambrosio, M., Keller, M., Hage, C. A., Schwartz, G., Keshavamurthy, S., Patel, V., Shah, R. D., Kasirajan, V., & Hashmi, Z. A. (2026). Outcomes of Lung Transplantation From Asphyxiation Donors: Reassessing Hypoxic Injury and Implications for Donation After Circulatory Death. Interdisciplinary CardioVascular and Thoracic Surgery, 41(5). https://doi.org/10.1093/icvts/ivag108

Vancouver

Kwon YIC, Ambrosio M, Keller M, Hage CA, Schwartz G, Keshavamurthy S, et al. Outcomes of Lung Transplantation From Asphyxiation Donors: Reassessing Hypoxic Injury and Implications for Donation After Circulatory Death. Interdisciplinary CardioVascular and Thoracic Surgery. 2026;41(5). doi:10.1093/icvts/ivag108

BibTeX
@article{Kwon2026,
  author = {Kwon, Ye In Christopher and Ambrosio, Matthew and Keller, Michael and Hage, Chadi A and Schwartz, Gary and Keshavamurthy, Suresh and Patel, Vipul and Shah, Rachit D and Kasirajan, Vigneshwar and Hashmi, Zubair A},
  title = {Outcomes of Lung Transplantation From Asphyxiation Donors: Reassessing Hypoxic Injury and Implications for Donation After Circulatory Death},
  journal = {Interdisciplinary CardioVascular and Thoracic Surgery},
  year = {2026},
  volume = {41},
  number = {5},
  doi = {10.1093/icvts/ivag108}
}
Kostenlos starten →